tiprankstipranks
Trending News
More News >
1933 Industries, Inc. (TSE:TGIF)
:TGIF
Canadian Market

1933 Industries (TGIF) AI Stock Analysis

Compare
96 Followers

Top Page

TS

1933 Industries

(TGIF)

Rating:44Neutral
Price Target:
The overall score reflects significant financial performance challenges, with declining revenues and high financial leverage being major concerns. Technical analysis indicators are limited, and valuation metrics also suggest caution. Corporate events, while aiming to improve financial flexibility, have a neutral impact. The company needs to address financial instability and improve profitability to enhance its outlook.

1933 Industries (TGIF) vs. iShares MSCI Canada ETF (EWC)

1933 Industries Business Overview & Revenue Model

Company Description1933 Industries Inc., a cannabis company, engages in the cultivation and production of cannabis products in the United States and Canada. The company produces, packages, and markets of cannabidiol (CBD)-infused products. It operates in the medical and recreational cannabis sectors. The company also offers CBD infused products, such as tinctures, vape pens and cartridges, lotions, pain creams, gummies, and capsules under the Canna Hemp and Canna Hemp X brands. In addition, it provides cannabis flowers and concentrates. The company offers CBD infused products through retail dispensaries, retail outlets, and e-commerce platform. 1933 Industries Inc. was formerly known as Friday Night Inc. and changed its name to 1933 Industries Inc. in September 2018. The company is headquartered in Vancouver, Canada.
How the Company Makes Money1933 Industries generates revenue through a multi-faceted business model that includes the sale of cannabis products and branded goods. The company operates cultivation facilities to produce high-quality cannabis flower and uses this raw material to create a range of products, including concentrates, edibles, and topicals. It sells these products through both wholesale and retail channels, targeting dispensaries and end consumers. Additionally, 1933 Industries collaborates with other brands and engages in licensing agreements to expand its product offerings and market reach. These partnerships and the company's integrated supply chain contribute significantly to its earnings by ensuring product availability and brand presence in key markets.

1933 Industries Financial Statement Overview

Summary
1933 Industries faces challenges with declining revenues and consistent net losses. The income statement indicates issues with profitability, and the balance sheet reveals financial instability due to high debt levels and negative equity. Cash flow shows some operational strength, but not enough to offset overall financial concerns.
Income Statement
45
Neutral
The company shows a declining trend in revenue and profitability metrics. The TTM Gross Profit Margin is around 10.8% and the Net Profit Margin is negative, indicating consistent losses. Revenue growth is negative, reflecting a decrease from the previous period. These factors highlight challenges in sustaining profitability and revenue growth.
Balance Sheet
30
Negative
The company has a high Debt-to-Equity ratio due to negative stockholders' equity, indicating financial instability. Return on Equity is not meaningful due to negative equity. The Equity Ratio is negative, underscoring the company's reliance on debt financing. Overall, the balance sheet reflects significant financial risk.
Cash Flow
50
Neutral
Positive operating cash flow suggests some ability to generate cash, but the Free Cash Flow Growth is inconsistent, with a slight improvement in the latest period. The Operating Cash Flow to Net Income Ratio is positive, suggesting better cash generation relative to reported losses. However, cash flow sustainability remains a concern.
Breakdown
TTMSep 2024Sep 2023Sep 2022Sep 2021Sep 2020
Income StatementTotal Revenue
17.50M19.35M18.27M12.54M11.98M11.96M
Gross Profit
1.90M2.94M-4.22M2.69M4.82M2.28M
EBIT
1.90M0.00-9.64M-4.81M-3.32M-16.63M
EBITDA
697.13K313.67K-10.03M-13.83M-2.71M-14.26M
Net Income Common Stockholders
-889.79K-1.14M-13.36M-18.07M-6.29M-20.02M
Balance SheetCash, Cash Equivalents and Short-Term Investments
318.57K449.18K1.09M363.27K4.41M2.76M
Total Assets
17.05M16.87M18.02M29.01M45.35M46.58M
Total Debt
17.79M16.78M17.57M17.68M17.87M25.74M
Net Debt
17.47M16.33M16.48M17.32M13.47M22.98M
Total Liabilities
22.61M21.70M23.28M21.49M20.12M27.13M
Stockholders Equity
-4.41M-3.53M-3.69M8.52M25.99M20.36M
Cash FlowFree Cash Flow
1.20M801.71K-2.33M-5.10M-5.12M-16.07M
Operating Cash Flow
1.69M1.69M-1.53M-5.09M-4.67M-14.98M
Investing Cash Flow
-381.39K-890.78K2.33M1.58K-456.36K-1.24M
Financing Cash Flow
-1.48M-1.46M-266.55K1.53M6.06M1.05M

1933 Industries Peers Comparison

Overall Rating
UnderperformOutperform
Sector (53)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
53
Neutral
$5.25B3.24-45.38%2.81%16.79%-0.06%
44
Neutral
C$2.45M
-9.20%93.62%
TSWIB
C$1.96M
$2.40M
$1.94M
40
Underperform
C$2.79M-21.61%
39
Underperform
C$1.34M-178.36%0.89%-179.36%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
TSE:TGIF
1933 Industries
0.01
0.00
0.00%
TSE:WIB
West Island Brands Inc
0.13
0.00
0.00%
THCBF
THC Biomed INTL
0.02
0.01
100.00%
BHHKF
Craftport Cannabis Corp
0.01
0.00
0.00%
TSE:VENI
Top Strike Resources
0.01
-0.02
-66.67%
TSE:XTRX
Adastra Labs Holdings Ltd.
0.16
-1.69
-91.35%

1933 Industries Corporate Events

Private Placements and FinancingBusiness Operations and Strategy
Zentek Launches US$30 Million At-The-Market Offering in U.S.
Positive
Mar 4, 2025

Zentek Ltd. has announced a US$30 million at-the-market offering in the United States, with Rodman & Renshaw LLC as the exclusive sales agent. The offering will be conducted on Nasdaq and other U.S. marketplaces, with proceeds intended for corporate purposes. This move is expected to enhance Zentek’s financial flexibility and support its growth strategy.

Financial Disclosures
1933 Industries Reports Q1 2025 Financial Results Amid Market Challenges
Negative
Feb 27, 2025

1933 Industries reported its first quarter financial results for 2025, showing a revenue of $4.0 million, a decrease from the previous year’s $5.2 million, attributed to soft sales and declining flower prices in Nevada. Despite a net loss of $0.6 million, the company maintained a strong market position, ranking third in cannabis sales in Nevada, reflecting its continued influence in the market despite economic challenges.

Glossary
OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.
NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.
UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.